ESBL production among E. coli and Klebsiella spp. Causing urinary tract infection: A hospital based study

Open Microbiology Journal

Volumn 11, Issue , 2017, Pages 23-30

  Shakya, Pooja ^a   Shrestha, Dhiraj ^b   Maharjan, Elina ^a   Sharma, Vijay K ^c   Paudyal, Rabin ^b  

^a National College of Food Science and Technology   (Nepal)

^b Trichandra College   (Nepal)

^c TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

Author keywords

E. coli; ESBL; Extended spectrum lactamase; Klebsiella; Nepal; Urinary tract infection; UTI

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; VANCOMYCIN;

ACINETOBACTER; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIURIA; CHILD; CITROBACTER; CROSS-SECTIONAL STUDY; DISK DIFFUSION; ENTEROBACTER; ENTEROCOCCUS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HUMAN; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; MORGANELLA; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA; PSEUDOMONAS; STAPHYLOCOCCUS; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

EID: 85020433145     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801711010023     Document Type: Article

References (48)

1. Khadka K, Khadka J, Lekhak B, Shrestha P, BR T. Incidence of urinary tract infection among the patients visiting Western Regional Hospital, Pokhara, Nepal. JHAS 2012; 2(1): 35-7.
2. Griebling TL. Urinary tract infection in women. In: Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2009; pp. 589-617.
3. Rai GK, Upreti HC, Rai SK, Shah KP, Shrestha RM. Causative agents of urinary tract infections in children and their antibiotic sensitivity pattern: a hospital based study. Nepal Med Coll J 2008; 10(2): 86-90. [PMID: 18828428]
4. Nachimuthu R, Chettipalayam S, Velramar B, Kurumandur R, Velu R. Urinary tract infection and antimicrobial susceptibility pattern of extended spectrum beta lactamase producing clinical isolates. Adv Biol Res (Faisalabad) 2008; 2(5-6): 78-82.
5. Dhillon RHP, Clark J. ESBLs: A clear and present danger? 2012. [http://dx.doi.org/10.1155/2012/625170]
6. Mehrgan H, Rahbar M. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 2008; 31(2): 147-51. [http://dx.doi.org/10.1016/j.ijantimicag.2007.09.008] [PMID: 18060745]
7. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18(4): 657-86. [http://dx.doi.org/10.1128/CMR.18.4.657-686.2005] [PMID: 16223952]
8. Vandana KE, Honnavar P, Amp C. Beta lactamases among ESBL producing Escherichia coli and Klebsiella pneumoniae If you don’t look, you won’t find. J Clin Diagn Res 2009; 3: 1653-6.
9. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 2009; 73(4): 345-54. [http://dx.doi.org/10.1016/j.jhin.2009.02.021] [PMID: 19596491]
10. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med 2005; 352(4): 380-91. [http://dx.doi.org/10.1056/NEJMra041359] [PMID: 15673804]
11. Aminzadeh Z, Sadat Kashi M, Shabani M. Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis 2008; 2(4): 197-200. [PMID: 19377237]
12. Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 2009; 3(4): 295-9. [PMID: 19759493]
13. Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59(2): 165-74. [http://dx.doi.org/10.1093/jac/dk1483] [PMID: 17158117]
14. Hammer DA, Dongol S, Anderson TP, Wong JS, Werno AM, Murdoch DR. High prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Nepal. Int J Antimicrob Agents 2007; 30(5): 471-2. [http://dx.doi.org/10.1016/j.ijantimicag.2007.07.004] [PMID: 17851048]
15. Ko KS, Suh JY, Peck KR, et al. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum β-lactamase-producing Escherichia coli isolated from urine and blood. Diagn Microbiol Infect Dis 2007; 58(1): 111-5. [http://dx.doi.org/10.1016/j.diagmicrobio.2006.11.015] [PMID: 17300900]
16. Vandepitte J, Engbaek K, Rohner P, Piot P, Heuck CC. Basic laboratory procedures in clinical bacteriology. 2 nd ed. Geneva: World Health Organization 2003.
17. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, Eds. Manual of Clinical Microbiology. 10 th ed. American Society of Microbiology 2011.
18. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Twenty-thi. Clinical and Laboratory Standards Institute 2013.
19. Kattel HP, Mishra SK, Acharya J, Singh AS, Rijal BP, Pokhrel BM. Relationship between pyuria and bacteriuria in suspected urinary tract infection. J Nepal Assoc Med Lab Sci 2009; 10: 19-21.
20. Baral P, Neupane S, Marasini BP, Ghimire KR, Lekhak B, Shrestha B. High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. BMC Res Notes 2012; 5: 38. [http://dx.doi.org/10.1186/1756-0500-5-38] [PMID: 22260454]
21. Bhatt C, Shrestha B, Khadka S, Swar S, Shah B, Pun K. Etiology of urinary tract infection and drug resistance cases of uropathoges. J Kathmandu Med Coll 2012; 1(2(2)): 114-0.
22. Behrooozi A, Rahbar M, Yousefi JV. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebseilla pneumonia isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res 2010; 4(9): 881-4.
23. Thakur S, Pokhrel N, Sharma M. Prevalence of multidrug resistant enterobacteriaceae and extended spectrum β lactamase producing Escherichia coli in urinary tract infection. Res J Pharm Biol Chem Sci 2013; 4(4): 1615-24.
24. Parajuli NP, Maharjan P, Parajuli H, et al. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control 2017; 6(1): 9. [http://dx.doi.org/10.1186/s13756-016-0168-6] [PMID: 28096977]
25. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott’s Diagnostic Microbiology. 12th ed. USA: Mosby Elsevier 2007.
26. Magliano E, Grazioli V, Deflorio L, et al. Gender and agedependent etiology of communityacquired urinary tract infections. Sci World J 2012; 2012: 349597. [http://dx.doi.org/10.1100/2012/349597]
27. McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med 2016; 22(11): 946-57. [http://dx.doi.org/10.1016/j.molmed.2016.09.003] [PMID: 27692880]
28. El-Mahmood AM, Atimi AT, Tirmidhi AB, Mohammed A. Antimicrobial susceptibility of some quinolone antibiotics against some urinary tract pathogens in a tertiary hospital, Yola, Adamawa State. Nig J Clin Med Res 2009; 1(2): 26-34.
29. Bhandari R, Pant ND, Poudel A, Sharma M. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal. BMC Res Notes 2016; 9(1): 390. [http://dx.doi.org/10.1186/s13104-016-2192-2] [PMID: 27488224]
30. Dongol P, Khanal H, Subba P, Benerjee JJ. Extended spectrum beta lactamases detection and multiple antibiotic resistance indexing of E. Coli from urine samples of patients from a referral hospital of eastern Nepal. Int J Appl Sci Biotechnol 2015; 3: 423. [http://dx.doi.org/10.3126/ijasbt.v3i3.12924]
31. Neupane S, Pant ND, Khatiwada S, Chaudhary R, Banjara MR. Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal. Antimicrob Resist Infect Control 2016; 5: 5. [http://dx.doi.org/10.1186/s13756-016-0104-9] [PMID: 26885364]
32. Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 2013; 7(10): 2173-7. [PMID: 24298468]
33. Somily AM, Habib HA, Absar MM, et al. ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia. J Infect Dev Ctries 2014; 8(9): 1129-36. [http://dx.doi.org/10.3855/jidc.4292] [PMID: 25212077]
34. Sibi G, Devi AP, Fouzia K, Patil BR. Prevalence, microbiologic profile of urinary tract infection and its treatment with trimethoprim in diabetic patients. Res J Microbiol 2011; 6(6): 543-51. [http://dx.doi.org/10.3923/jm.2011.543.551]
35. Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes 2013; 6: 487. [http://dx.doi.org/10.1186/1756-0500-6-487] [PMID: 24274894]
36. Mahdi Yahya Mohsen S, Hamzah HA, Muhammad Imad Al-Deen M, Baharudin R. Antimicrobial susceptibility of klebsiella pneumoniae and Escherichia coli with extended-spectrum β-lactamase associated genes in hospital Tengku Ampuan Afzan, Kuantan, Pahang. Malays J Med Sci 2016; 23(2): 14-20. [PMID: 27547110]
37. Pokhrel RH, Thapa B, Kafle R, Shah PK, Tribuddharat C. Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal. BMC Res Notes 2014; 7: 694. [http://dx.doi.org/10.1186/1756-0500-7-694] [PMID: 25287013]
38. Yadav KK, Adhikari N, Khadka R, Pant AD, Shah B. Multidrug resistant Enterobacteriaceae and extended spectrum β-lactamase producing Escherichia coli: a cross-sectional study in National Kidney Center, Nepal. Antimicrob Resist Infect Control 2015; 4: 42. [http://dx.doi.org/10.1186/s13756-015-0085-0] [PMID: 26504518]
39. Lakshmi B, Lakshmi MS. Microbiological profile of urinary tract infections and prevalence of extended spectrum beta lactamase producing. J Evol Med Dent Sci 2014; 3(32): 8766-74.
40. Shah R, Singh Y, Sanjana R. Study of Extended spectrum beta-lactamases (ESBLs) producing Klebsiella species in various clinical specimens: A preliminary report. J Coll Med Sci 2010; 6(3): 19-23.
41. Akpaka PE, Swanston WH. Phenotypic detection and occurrence of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli at a tertiary hospital in Trinidad & Tobago. Braz J Infect Dis 2008; 12(6): 516-20. [http://dx.doi.org/10.1590/S1413-86702008000600014] [PMID: 19287841]
42. Mekki AH, Hassan AN, Elsayed DE. Extended spectrum beta lactamases among multi drug resistant Escherichia coli and Klebsiella species causing urinary tract infections in Khartoum. J Bacteriol Res 2010; 2(3): 18-21.
43. Poudyal S, Bhatta DR, Shakya G, et al. Extended spectrum â-lactamase producing multidrug resistant clinical bacterial isolates at National Public Health Laboratory, Nepal. Nepal Med Coll J 2011; 13(1): 34-8. [PMID: 21991699]
44. Roopa TJ, Sudha SS. Antimicrobial susceptibility of extended spectrum β -lactamase (ESBL) producing uropathogens isolated from ICU patients. Int J Biol Technol 2010; 1(3): 23-31.
45. Gyawali S, Shankar PR, Poudel PP, Saha A. Knowledge, attitude and practice of self-medication among basic science undergraduate medical students in a medical school in western Nepal. J Clin Diagn Res 2015; 9(12): FC17-22. [PMID: 26816912]
46. Shankar PR, Partha P, Shenoy N. Self-medication and non-doctor prescription practices in Pokhara valley, Western Nepal: a questionnaire-based study. BMC Fam Pract 2002; 3: 17. [http://dx.doi.org/10.1186/1471-2296-3-17] [PMID: 12236905]
47. Ullah F, Malik SA, Ahmed J. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol 2009; 8(16): 3921-6.
48. Han SB, Lee SC, Lee SY, Jeong DC, Kang JH. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. BMC Infect Dis 2015; 15: 414. [http://dx.doi.org/10.1186/s12879-015-1153-z] [PMID: 26464143]